| For: | Cicala M, Emerenziani S, Guarino MPL, Ribolsi M. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol 2013; 19(39): 6529-6535 [PMID: 24151377 DOI: 10.3748/wjg.v19.i39.6529] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i39/6529.htm |
| Number | Citing Articles |
| 1 |
Hiroto Miwa, Takashi Kondo, Tadayuki Oshima. Gastroesophageal reflux disease-related and functional heartburn. Current Opinion in Gastroenterology 2016; 32(4) doi: 10.1097/MOG.0000000000000282
|
| 2 |
Daniel Runggaldier, Baselt Bastian, Naomi Iob, Cosima Riemenschnitter, Christian Thüring, Jérôme R. Lechien, Jérôme Bonzon, Jörg E. Bohlender, Grégoire B. Morand. Inverse correlation between acid reflux and dwell time of voice protheses (Provox®) in laryngectomy/laryngopharyngectomy patients: a retrospective analysis of a prospective cohort. European Archives of Oto-Rhino-Laryngology 2026; 283(8) doi: 10.1007/s00405-026-10370-1
|
| 3 |
Zilla H Hussain, Emily E Henderson, Carla Maradey-Romerao, Nina George, Ronnie Fass, Brian E Lacy. The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clinical and Translational Gastroenterology 2015; 6(8) doi: 10.1038/ctg.2015.32
|
| 4 |
Katsuhiko Iwakiri, Yuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, Kentaro Kudou, Akira Nishimura, Naoki Hiramatsu, Eiji Umegaki, Kiyoshi Ashida. A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. Therapeutic Advances in Gastroenterology 2017; 10(6) doi: 10.1177/1756283X17705329
|
| 5 |
Diana M. Orbelo, Felicity T. Enders, Yvonne Romero, Dawn L. Francis, Sami R. Achem, Tushar S. Dabade, Michael D. Crowell, Debra M. Geno, Ramona S. DeJesus, Vikneswaran Namasivayam, Steven C. Adamson, Amindra S. Arora, Andrew J. Majka, Jeffrey A. Alexander, Joseph A. Murray, Matthew Lohse, Nancy N. Diehl, Mary Fredericksen, Kee Wook Jung, Margaret S. Houston, Angela E. O’Neil, David A. Katzka. Once-Daily Omeprazole/Sodium Bicarbonate Heals Severe Refractory Reflux Esophagitis with Morning or Nighttime Dosing. Digestive Diseases and Sciences 2015; 60(1) doi: 10.1007/s10620-013-3017-y
|
| 6 |
M. Ribolsi, P. Balestrieri, R. H Holloway, S. Emerenziani, M. Cicala. Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate. Diseases of the Esophagus 2016; 29(8) doi: 10.1111/dote.12434
|
| 7 |
I V Maev, E V Barkalova, M A Ovsepyan, Yu A Kucheryavyi, D N Andreev. Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease. Terapevticheskii arkhiv 2017; 89(2) doi: 10.17116/terarkh201789276-83
|
| 8 |
N B Lishchuk, V I Simanenkov, S V Tikhonov. Differentiation therapy for non-acidic gastroesophageal reflux disease. Terapevticheskii arkhiv 2017; 89(4) doi: 10.17116/terarkh201789457-63
|
| 9 |
Jamie-Lee DeBattista, Graziella Zahra, Christopher Barbara, John Schembri, Lilian M. Azzopardi, Francesca Wirth. CYP2C19 genetic polymorphisms and proton pump inhibitor therapy resistance in patients with gastrooesophageal reflux disease: a preliminary observational cohort study. Drug Metabolism and Personalized Therapy 2026; 41(1) doi: 10.1515/dmpt-2025-0077
|
| 10 |
Mentore Ribolsi, Lorenzo Marchetti, Chiara Catamo, Laura Galdi, Marco Distefano, Michele Cicala. Quantifying Esophageal Hydrogen Ion Exposure Using a Novel pH-Impedance Metric Improves Prediction of Proton Pump Inhibitor Response Compared With Conventional Acid Exposure Time in Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2026; doi: 10.14309/ajg.0000000000004092
|
| 11 |
Marzio Frazzoni, Micaela Piccoli, Rita Conigliaro, Leonardo Frazzoni, Gianluigi Melotti. Laparoscopic fundoplication for gastroesophageal reflux disease. World Journal of Gastroenterology 2014; 20(39): 14272-14279 doi: 10.3748/wjg.v20.i39.14272
|
| 12 |
Qian Jun Zhuang, Nian Di Tan, Song Feng Chen, Meng Yu Zhang, Ying Lian Xiao. Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta‐analysis. Journal of Digestive Diseases 2021; 22(12) doi: 10.1111/1751-2980.13063
|
| 13 |
Bibek Das, Marcus Reddy, Omar A. Khan. Is the Stretta procedure as effective as the best medical and surgical treatments for gastro-oesophageal reflux disease? A best evidence topic. International Journal of Surgery 2016; 30 doi: 10.1016/j.ijsu.2016.03.062
|
| 14 |
Roman Vasiliev, Igor Maev Igor Maev, Igor Bakulin, Dmitriy Bordin Dmitriy Bordin, Nataliya Bakulina, Inna Oganezova, Ekaterina Skazyvaeva, Maria Skalinskaya, Yulia Embutnieks Yulia Embutnieks, Roman Plavnik, Lyudmila Fedulenkova Lyudmila Fedulenkova, Sergey Tikhonov, Mariia Zhuravleva Mariia Zhuravleva. Epidemiological and clinical risk factors for non-erosive reflux disease, erosive esophagitis and Barrett’s esophagus in Russia. Gastroenterology & Hepatology: Open Access 2021; 12(6) doi: 10.15406/ghoa.2021.12.00482
|
| 15 |
Woretaw Sisay Zewdu, Tezera Jemere Aragaw. <p>Evaluation of the Anti-Ulcer Activity of Hydromethanolic Crude Extract and Solvent Fractions of the Root of <em>Rumex nepalensis</em> in Rats</p>. Journal of Experimental Pharmacology 2020; doi: 10.2147/JEP.S258586
|
| 16 |
J. Sunwoo, J. Oh, S. J. Moon, S. C. Ji, S. H. Lee, K.‐S. Yu, H. S. Kim, A. Lee, I.‐J. Jang. Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium‐competitive acid blocker, in healthy male subjects. Alimentary Pharmacology & Therapeutics 2018; 48(2) doi: 10.1111/apt.14818
|
| 17 |
James H. Clark, Zilla Hussain, Lee Akst, Stanley L. Marks, Peter C. Belafsky. Histamine 2‐Receptor Antagonists Tachyphylaxis: A Scoping Review. The Laryngoscope 2026; 136(6) doi: 10.1002/lary.70337
|
| 18 |
I. V. Maev, E. V. Barkalova, M. A. Hovsepyan, Yu. A. Kucheryavy, Dmitry N. Andreyev. Esophageal manometry high-resolution in
clinical practice.. Clinical Medicine (Russian Journal) 2018; 95(12) doi: 10.18821/0023-2149-2017-95-12-1127-1136
|
| 19 |
Akinari Sawada, Daniel Sifrim, Yasuhiro Fujiwara. Esophageal Reflux Hypersensitivity: A Comprehensive Review. Gut and Liver 2023; 17(6) doi: 10.5009/gnl220373
|
| 20 |
María Puig-Moltó, Blanca Lumbreras, Elsa López-Pintor. Improving Proton-Pump Inhibitor Adherence Intervention Between Primary Care and Community Pharmacies: A Pre-Post Intervention Study. Patient Preference and Adherence 2024; doi: 10.2147/PPA.S485307
|
| 21 |
Ryo Kato, Kiyokazu Nakajima, Tsuyoshi Takahashi, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki. A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0162-5
|
| 22 |
Zhengcai Lou. It is vital to identify the underlying cause of chronic laryngopharyngeal neuropathy. American Journal of Otolaryngology 2018; 39(1) doi: 10.1016/j.amjoto.2017.11.001
|
| 23 |
Jiaqi Liu, Jongsung Hahn. Clinical pharmacokinetics of potassium competitive acid blockers: a systematic review and meta-analysis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1580969
|
| 24 |
S. Yi, H. Lee, S. B. Jang, H. M. Byun, S. H. Yoon, J.‐Y. Cho, I.‐J. Jang, K.‐S. Yu. A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers. Alimentary Pharmacology & Therapeutics 2017; 46(3) doi: 10.1111/apt.14148
|
| 25 |
Neha Deshpande, Sharanya V., Ravi Kanth V. V., Murthy H. V. V., Sasikala M., Rupa Banerjee, Manu Tandan, Nageshwar Reddy D.. Rapid and ultra-rapid metabolizers with CYP2C19 *17 polymorphism do not respond to standard therapy with proton pump inhibitors. Meta Gene 2016; 9 doi: 10.1016/j.mgene.2016.06.004
|
| 26 |
Elisa Marabotto, Andrea Pasta, Francesco Calabrese, Mentore Ribolsi, Amir Mari, Vincenzo Savarino, Edoardo Vincenzo Savarino. The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions. Visceral Medicine 2024; 40(5) doi: 10.1159/000536583
|
| 27 |
Kayo Akutagawa, Ryuichi Iwakiri, Megumi Hara, Kazuma Fujimoto, Yasuhiro Fujiwara, Masahiko Inamori, Junji Tanaka, Tomohiko Shimatani, Junichi Akiyama, Takashi Ando, Noriaki Manabe, Fukunori Kinjo, Ryuzo Deguchi, Motoyasu Kusano. Risk factors for low response to proton-pump inhibitor treatment in reflux esophagitis and non-erosive reflux disease evaluated by the frequency scale for the symptoms of gastroesophageal reflux disease. Esophagus 2015; 12(3) doi: 10.1007/s10388-014-0477-x
|
| 28 |
A. S. Trukhmanov, D. E. Rumyantseva. Potassium-Competitive Acid Blockers: New Opportunities of Antisecretory Therapy in Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(4) doi: 10.22416/1382-4376-2025-35-4-18-26
|
| 29 |
Zhi-Tong Li, Feng Ji, Xin-Wei Han, Rui Zhang, Li-Dong Chen, Chun-Xia Li, Li-Li Yuan, Zhong-Gao Wang, Kang-Dong Liu. Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study. Surgical Endoscopy 2021; 35(7) doi: 10.1007/s00464-021-08397-y
|
| 30 |
Rajesh Upadhyay, Sunil Jaiswal, Ashish Mungantiwar, Shreshth Nayar, Navin K Soni, Ashwin A Kotamkar, Azra Naseem, Aaditi Phadke, Shailesh Pallewar, Parvan Shetty, Amit Qamra. High Dose Pantoprazole for Gastroesophageal Reflux Disease: Need, Evidence, Guidelines and Our Experience. Euroasian journal of hepato-gastroenterology 2024; 14(1) doi: 10.5005/jp-journals-10018-1426
|
| 31 |
Yue Hu, Meng Zhang, Bin Lu, Jinfeng Dai. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter 2016; 21(5) doi: 10.1111/hel.12299
|
| 32 |
I. G. Pakhomova. Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study. Medical Council 2019; (14) doi: 10.21518/2079-701X-2019-14-10-16
|
| 33 |
Hai-Xiang Yu, Chun-Shan Han, Jin-Ru Xue, Zhi-Feng Han, Hua Xin. Esophageal hiatal hernia: risk, diagnosis and management. Expert Review of Gastroenterology & Hepatology 2018; 12(4) doi: 10.1080/17474124.2018.1441711
|
| 34 |
Mengyu Zhang, Minhu Chen, Sui Peng, Yinglian Xiao. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. United European Gastroenterology Journal 2018; 6(3) doi: 10.1177/2050640617735084
|
| 35 |
T. V. K. Herregods, M. Troelstra, P. W. Weijenborg, A. J. Bredenoord, A. J. P. M. Smout. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterology & Motility 2015; 27(9) doi: 10.1111/nmo.12620
|
| 36 |
Nicola de Bortoli, Marzio Frazzoni, Edoardo Savarino. Diagnosis and Endoscopic Management of Digestive Diseases. 2017; doi: 10.1007/978-3-319-42358-6_14
|
| 37 |
Yoshimasa Hoshikawa, Shintaro Hoshino, Noriyuki Kawami, Katsuhiko Iwakiri. Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms. Journal of Gastroenterology 2021; 56(2) doi: 10.1007/s00535-020-01751-2
|
| 38 |
Ying-Nan Li, Xiao-Ning Zhao, Ting-Ting Li, Chang-Zheng Wang, Wei-Hua Wang, Lei Tian, Ben-Yan Wu. Clinical Characteristics of Elderly Patients with Refractory Gastroesophageal Reflux Disease. International Journal of Gerontology 2016; 10(2) doi: 10.1016/j.ijge.2015.03.003
|
| 39 |
Shiyu Zhang, Xiaoyan Wang, Xuelian Xiang, Huiying Yang, Nana Tang, Li Liu, Bo Jiang. A Prospective Trial to Access the Optimal Circumference of Resection in Antireflux Mucosectomy for Treatment-refractory GERD. Journal of Clinical Gastroenterology 2022; 56(5) doi: 10.1097/MCG.0000000000001650
|
| 40 |
Kornilia Nikaki, Anna Rybak, Kenichiro Nakagawa, David Rawat, Etsuro Yazaki, Philip Woodland, Osvaldo Borrelli, Daniel Sifrim. Rumination Syndrome in Children Presenting With Refractory Gastroesophageal Reflux Symptoms. Journal of Pediatric Gastroenterology and Nutrition 2020; 70(3) doi: 10.1097/MPG.0000000000002569
|
| 41 |
Yu. V. Evsyutina, A. S. Trukhmanov. Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics. Terapevticheskii arkhiv 2015; 87(2) doi: 10.17116/terarkh201587285-89
|
| 42 |
Jérôme R. Lechien, Francois Bobin, Vinciane Muls, Francois Mouawad, Giovanni Dapri, Didier Dequanter, Mihaela Horoi, Marie‐Paule Thill, Alexandra Rodriguez Ruiz, Sven Saussez. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients. The Laryngoscope 2021; 131(6) doi: 10.1002/lary.28962
|
| 43 |
Jiten P. Kothadia, Colin W. Howden. Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease. Foregut: The Journal of the American Foregut Society 2024; 4(1) doi: 10.1177/26345161231181357
|
| 44 |
Dalia E. Ali, Othman S. S. Al-Hawshabi, Sarah A. Abd El-Aal, Eman Sheta, Sherihan Salaheldin Abdelhamid Ibrahim, Amira A. El-Gazar, Essam Abdel-Sattar, Ghada M. Ragab. Gastroprotective effect of Arabincoside B isolated from Caralluma arabica against ethanol-induced gastric injury via modulating oxidative stress/SP/NK-1R/NF-κB loop. Inflammopharmacology 2025; 33(8) doi: 10.1007/s10787-025-01885-w
|
| 45 |
A. V. Paraskevova, A. S. Trukhmanov, O. A. Storonova, S. V. Lyamina, S. V. Kalish, S. S. Pirogov, A. B. Ponomarev, D. E. Rumyantseva, I. Yu. Malyshev, I. V. Maev, V. T. Ivashkin. Macrophage phenotype after human refluxate exposure, esophageal dysmotility and their correlation with gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(1) doi: 10.22416/1382-4376-2022-32-1-24-33
|
| 46 |
Yung Lee, Umair Tahir, Lea Tessier, Kevin Yang, Taaha Hassan, Jerry Dang, Matthew Kroh, Dennis Hong. Long-term outcomes following Dor, Toupet, and Nissen fundoplication: a network meta-analysis of randomized controlled trials. Surgical Endoscopy 2023; 37(7) doi: 10.1007/s00464-023-10151-5
|
| 47 |
Mentore Ribolsi, Michele Cicala, Patrizia Zentilin, Matteo Neri, Aurelio Mauro, Konstantinos Efthymakis, Tommasangelo Petitti, Vincenzo Savarino, Roberto Penagini. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease. Alimentary Pharmacology & Therapeutics 2018; 48(10) doi: 10.1111/apt.14986
|
| 48 |
Wei-Tao Liang, Zhong-Gao Wang, Feng Wang, Yue Yang, Zhi-Wei Hu, Jian-Jun Liu, Guang-Chang Zhu, Chao Zhang, Ji-Min Wu. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-178
|
| 49 |
Amit Elad, Botros Moalem, Dana Sender, Aya Bardugo, Ki-Suk Kim, Yhara Arad, Haya Benhayon, Ayelet Gal Etzyoni, Nehemia Greenstein, Aviv Halfon, Sarah Knapp, Michelle Malis, Bailey Peck, Itia Samuel, Amram Kupietzky, Saleh Daher, Esther Forkosh, David Hakimian, Tiberiu Hershcovici, Nadav Ilani, Lior Katz, Moshe Rottenstreich, Elez Vainer, Yuval Ishay, Eitan Zlotnick, Abed Nasereddin, Idid Shiff, Ariel Benson, Ronit Grinbaum, Siddhartha Mishra, Shlomi Kotler, Linda C. Samuelson, Darleen A. Sandoval, Rachel Ben-Haroush Schyr, Danny Ben-Zvi. Sleeve gastrectomy reveals the plasticity of the human gastric epithelium. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-56135-y
|
| 50 |
Xu Han, Yawen Zhang, Allen Lee, Zhaoshen Li, Jun Gao, Xiaoyin Wu, Jiulong Zhao, Hui Wang, Di Chen, Duowu Zou, Chung Owyang. Upregulation of acid sensing ion channels is associated with esophageal hypersensitivity in GERD. The FASEB Journal 2022; 36(1) doi: 10.1096/fj.202100606R
|
| 51 |
Ying Lian Xiao, Meng Yu Zhang, Nian Di Tan, Song Feng Chen, Qian Jun Zhuang, Min Hu Chen. Patient‐ and physician‐reported satisfaction with gastroesophageal reflux disease (GERD) treatment in Chinese clinical practice. Journal of Digestive Diseases 2022; 23(5-6) doi: 10.1111/1751-2980.13104
|
| 52 |
H. Jenkins, Y. Sakurai, A. Nishimura, H. Okamoto, M. Hibberd, R. Jenkins, T. Yoneyama, K. Ashida, Y. Ogama, S. Warrington. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects. Alimentary Pharmacology & Therapeutics 2015; 41(7) doi: 10.1111/apt.13121
|
| 53 |
Mentore Ribolsi, Edoardo Savarino. Towards a better diagnosis of gastro esophageal reflux disease. Expert Review of Gastroenterology & Hepatology 2023; 17(10) doi: 10.1080/17474124.2023.2267435
|
| 54 |
Arthur Laquière, Felix Trottier-Tellier, Romina Urena-Campos, Pascal Lienne, Laurence Lecomte, Maria Katsogiannou, Guillaume Penaranda, Christian Boustière, Masanao Nakamura. Evaluation of Antireflux Mucosectomy for Severe Gastroesophageal Reflux Disease: Medium-Term Results of a Pilot Study. Gastroenterology Research and Practice 2022; 2022 doi: 10.1155/2022/1606944
|
| 55 |
М. Ю. Попович. ЧАСТОТА ТА ОСОБЛИВОСТІ УРАЖЕННЯ ВЕРХНІХ ВІДДІЛІВ ШЛУНКОВО-КИШКОВОГО ТРАКТУ У ХВОРИХ ІЗ ЛІМФОПРОЛІФЕРАТИВНИМИ ЗАХВОРЮВАННЯМИ ТА ЗАЛІЗОДЕФІЦИТНОЮ АНЕМІЄЮ ЖИТЕЛІВ ЗАКАРПАТТЯ. Здобутки клінічної і експериментальної медицини 2023; (4) doi: 10.11603/1811-2471.2023.v.i4.14307
|
| 56 |
Pier Alberto Testoni, Sabrina Gloria Giulia Testoni. Targeted Endoscopic Therapies for Gastro-Esophageal Reflux Disease (GERD): A Narrative Review. Journal of Personalized Medicine 2026; 16(4) doi: 10.3390/jpm16040190
|
| 57 |
Hira Imam, Arham Shabbir, Anum Jamil, Adeel Masood Butt, Tabinda Fatima, Esraa M. Haji, Farhan K. Alswailmi, Ali F. Almutairy, Mujeeb Ur Rehman Parrey, Ashfaq Ahmad. Protective effects of vincamine against ethanol-induced gastric ulcer by attenuation of IL-6, IL-1β, and TNF-α mRNA expression levels in the gastric mucosa of BALB/c mice. Journal of Molecular Histology 2025; 56(2) doi: 10.1007/s10735-025-10374-x
|
| 58 |
Diana L. Snyder, David A. Katzka. Complex Gastroesophageal Reflux Disease. Gastro Hep Advances 2022; 1(3) doi: 10.1016/j.gastha.2022.02.014
|
| 59 |
Marzio Frazzoni, Helga Bertani, Raffaele Manta, Vincenzo Giorgio Mirante, Leonardo Frazzoni, Rita Conigliaro, Gianluigi Melotti. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Digestive and Liver Disease 2014; 46(7) doi: 10.1016/j.dld.2014.03.005
|
| 60 |
Rena Yadlapati, Michael Tye, Sabine Roman, Peter J. Kahrilas, Katherine Ritter, John E. Pandolfino. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors. Clinical Gastroenterology and Hepatology 2018; 16(2) doi: 10.1016/j.cgh.2017.09.011
|
| 61 |
Sundeep Lakhtakia, Aniruddha P Singh, Neeraj Singla, Sana F Memon, Duvvur N Reddy. Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open‐label, single‐arm pilot study. JGH Open 2024; 8(2) doi: 10.1002/jgh3.12988
|
| 62 |
Chao Zhang, Jimin Wu, Zhiwei Hu, Chao Yan, Xiang Gao, Weitao Liang, Diangang Liu, Fei Li, Zhonggao Wang, Masaru Katoh. Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring. PLOS ONE 2016; 11(8) doi: 10.1371/journal.pone.0160139
|
| 63 |
Rishi D. Naik, Michael F. Vaezi. Recent advances in diagnostic testing for gastroesophageal reflux disease. Expert Review of Gastroenterology & Hepatology 2017; 11(6) doi: 10.1080/17474124.2017.1309286
|
| 64 |
Prashanth Rawla, Tagore Sunkara, Andrew Ofosu, Vinaya Gaduputi. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2018; 9(7): 63-68 doi: 10.4292/wjgpt.v9.i7.63
|
| 65 |
Mentore Ribolsi, Antonio Giordano, Michele Pier Luca Guarino, Alessandro Tullio, Michele Cicala. New classifications of gastroesophageal reflux disease: an improvement for patient management?. Expert Review of Gastroenterology & Hepatology 2019; 13(8) doi: 10.1080/17474124.2019.1645596
|
| 66 |
Pier Alberto Testoni, Sabrina Testoni. Functional Diseases of the Esophagus. Updates in Surgery 2026; doi: 10.1007/978-3-031-90570-4_6
|
| 67 |
I V Maev, D N Andreev, Yu A Kucheryavyy, R I Shaburov. Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection. Terapevticheskii arkhiv 2019; 91(8) doi: 10.26442/00403660.2019.08.000387
|
| 68 |
Amira Soliman, Leyanis Rodriguez-Vera, Ana Alarcia-Lacalle, Leandro F. Pippa, Saima Subhani, Viera Lukacova, Jorge Duconge, Natalia V. de Moraes, Valvanera Vozmediano. Leveraging Omeprazole PBPK/PD Modeling to Inform Drug–Drug Interactions and Specific Recommendations for Pediatric Labeling. Pharmaceutics 2025; 17(3) doi: 10.3390/pharmaceutics17030373
|
| 69 |
Yu Liang, Zhen Meng, Xue-Li Ding, Man Jiang. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review. World Journal of Gastroenterology 2024; 30(21): 2751-2762 doi: 10.3748/wjg.v30.i21.2751
|
| 70 |
Farzaneh Banki. Gastroesophageal Reflux Disease: Critical Aspects of the History. Foregut: The Journal of the American Foregut Society 2023; 3(3) doi: 10.1177/26345161231170287
|
| 71 |
Dong Kyu Kim, Keun-Ho Lee, Sung-jun Kim, Soo-Jin Kim, Song Jin Lee, Chi Hye Park, Bong-Tae Kim, Geun-Seog Song, Byoung-Seok Moon, Shin-Young Ryu. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid–Related Disease. The Journal of Pharmacology and Experimental Therapeutics 2019; 369(3) doi: 10.1124/jpet.118.254904
|
| 72 |
Benjamin D. Rogers, C. Prakash Gyawali. Enhancing High-Resolution Esophageal Manometry. Gastroenterology Clinics of North America 2020; 49(3) doi: 10.1016/j.gtc.2020.04.001
|
| 73 |
Tarek M. Yosef, Ahmed ElMetwally Ahmed, Ahmed Mansour, Mahmoud Ahmed AbuFayyoud, Ahmed M ElGhandour. Evaluation of serum levels of Interleukin-4 in Egyptian patients with refractory gastroesophageal reflux disease. Alexandria Journal of Medicine 2020; 56(1) doi: 10.1080/20905068.2020.1845441
|
| 74 |
Alessio Ardizzone, Deborah Mannino, Giovanna Casili, Michela Campolo, Irene Paterniti, Marika Lanza, Alessia Filippone, Alberto Repici, Valentina Bova, Anna Paola Capra, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease. Phytotherapy Research 2024; 38(3) doi: 10.1002/ptr.8133
|